Macquarie Group Portfolio holdings
AUM
$81.5B
1-Year Return
21.2%
This Quarter Return
+1.78%
1 Year Return
+21.2%
3 Year Return
+85%
5 Year Return
+166.7%
10 Year Return
+339.95%
AUM
$82.4B
AUM Growth
-$10.2B
(-11%)
Cap. Flow
-$4.86B
Cap. Flow
% of AUM
-5.89%
Top 10 Holdings %
Top 10 Hldgs %
17.49%
Holding
1,763
New
102
Increased
607
Reduced
688
Closed
91
Top Buys
| 1 |
Analog Devices
ADI
|
$252M |
| 2 |
Dimensional International Value ETF
DFIV
|
$201M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
$160M |
| 4 |
Bank of America
BAC
|
$146M |
| 5 |
monday.com
MNDY
|
$124M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
$398M |
| 2 |
NVIDIA
NVDA
|
$325M |
| 3 |
Motorola Solutions
MSI
|
$305M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$236M |
| 5 |
Air Products & Chemicals
APD
|
$220M |
Sector Composition
| 1 | Technology | 26.79% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 11.79% |
| 4 | Industrials | 10.8% |
| 5 | Consumer Discretionary | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1401
UBS Group
UBS
$128B
| $428K | ﹤0.01% |
14,000
| – | – |
|
1402
Paycom
PAYC
$12.6B
| $424K | ﹤0.01% |
3,980
+2,115
| +113% | +$225K |
|
1403
Dorchester Minerals
DMLP
$1.18B
| $421K | ﹤0.01% |
12,617
-79
| -0.6% | -$2.64K |
|
|
CLLS
1404
Cellectis
CLLS
$269M
| $408K | ﹤0.01% |
226,875
| – | – |
|
1405
Sangamo Therapeutics
SGMO
$165M
| $408K | ﹤0.01% |
400,000
| – | – |
|
1406
Franklin Resources
BEN
$13B
| $401K | ﹤0.01% |
31,768
+13,152
| +71% | +$166K |
|
1407
MINISO
MNSO
$7.49B
| $400K | ﹤0.01% |
16,732
| – | – |
|
1408
Arcos Dorados Holdings
ARCO
$1.47B
| $397K | ﹤0.01% |
54,469
| – | – |
|
1409
Bio-Rad Laboratories Class A
BIO
$8B
| $397K | ﹤0.01% |
1,207
+79
| +7% | +$26K |
|
1410
Hormel Foods
HRL
$14.1B
| $395K | ﹤0.01% |
23,863
+12,475
| +110% | +$206K |
|
1411
Ferrovial SE
FER
$40B
| $379K | ﹤0.01% |
9,025
+81
| +0.9% | +$3.4K |
|
|
UMH
1412
UMH Properties
UMH
$1.29B
| $369K | ﹤0.01% |
19,531
+6,620
| +51% | +$125K |
|
1413
XPeng
XPEV
$18.9B
| $367K | ﹤0.01% |
31,008
-49,048
| -61% | -$580K |
|
|
NTST
1414
NETSTREIT Corp
NTST
$1.72B
| $366K | ﹤0.01% |
25,882
-11,892
| -31% | -$168K |
|
1415
Albemarle
ALB
$9.6B
| $361K | ﹤0.01% |
8,743
+4,970
| +132% | +$205K |
|
1416
HEICO
HEI
$44.8B
| $344K | ﹤0.01% |
1,449
+173
| +14% | +$41.1K |
|
1417
Karyopharm Therapeutics
KPTI
$57.2M
| $338K | ﹤0.01% |
33,333
| – | – |
|
1418
Rivian
RIVN
$17.2B
| $327K | ﹤0.01% |
24,591
+2,919
| +13% | +$38.8K |
|
1419
Kanzhun
BZ
$11.1B
| $325K | ﹤0.01% |
23,533
| – | – |
|
1420
Liberty Global Class C
LBTYK
$4.12B
| $323K | ﹤0.01% |
24,597
| – | – |
|
1421
Ero Copper
ERO
$1.55B
| $314K | ﹤0.01% |
23,619
+1,385
| +6% | +$18.4K |
|
1422
Allogene Therapeutics
ALLO
$255M
| $313K | ﹤0.01% |
146,779
| – | – |
|
|
VRE
1423
Veris Residential
VRE
$1.52B
| $312K | ﹤0.01% |
18,759
-9,168
| -33% | -$152K |
|
1424
AMC Networks
AMCX
$328M
| $305K | ﹤0.01% |
30,800
| – | – |
|
|
PGRE
1425
Paramount Group
PGRE
$1.66B
| $302K | ﹤0.01% |
61,090
| – | – |
|